Trinity, St. James’s and Legend Biotech collaborating on solid tumors
Trinity College and St. James’s Hospital Dublin (SJH) in Ireland have entered into a strategic…
28/06/2022 - 3 minutes
Solid tumors
A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
11/10/2021 - 10 minutes
This Cancer Immunotherapy Attacks the Sugar Coat of Tumor Cells
The Portuguese company CellmAbs is developing cancer immunotherapies that prevent tumor cells from evading the…
31/01/2020 - 3 minutes
Merck Spinout Bags €15M Series A to Tackle Cancer and Fibrosis
iOnctura, a spinout from Merck KGaA, has raised €15M to take its cancer and fibrosis…
23/01/2020 - 2 minutes
Why Orthotopic Tumor Models Are Key to Successful Cancer Therapies
One of the greatest challenges faced by researchers in preclinical oncology studies is the translatability…
08/07/2019 - 7 minutes
UK Biotech Gets Huge Grant to Launch Off-the-Shelf CAR-T Cancer Therapy to Clinic
The UK biotech Cell Medica has received a €7.6M ($8.7M) grant from the Cancer Prevention…
27/02/2019 - 3 minutes
CAR-T Brings Hope for Cancer Patients, But Challenges Lie Ahead
CAR-T cell therapy has been able to effectively treat cancer in some patients for whom…
13/06/2018 - 5 minutes
German Pharma Enters the Clinic with Solid Tumor Treatment
A Phase I study will investigate the safety and tolerability of Immatics approach to treating…
28/09/2017 - 2 minutes
German Biotech Starts Trials with a Personalized Cell Therapy for Multiple Cancers
Immatics will start a first clinical trial to test IMA101, a personalized cell therapy with…
21/08/2017 - 3 minutes
Swedish Biotech publishes Long-Term Data on a Dendritic Cell Therapy for Cancer
Immunicum has reported new data on long-term follow-up of patients treated with ilixadencel, a unique…
20/06/2017 - 3 minutes
Next-Gen Cancer Antibody Technology from Germany enters the Clinic
Apogenix' partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the…
13/04/2017 - 2 minutes
“In the Coming Decade, Off-the-Shelf Cell Therapy will Become a Reality”
David Sourdive, co-founder of Cellectis, discusses his pioneering work developing off-the-shelf CAR-T for cancer and…
16/03/2017 - 4 minutes
